SWX SP HLTHCARE2 TR
3.328,94PKT
+2,47 (+0,07%)
30.01.2023, 17:31:43 Uhr
WKN: ISIN: CH0022654005 Wertpapiertyp: Index Währung: Punkte
Börse: Schweiz
Weltmärkte
- DAX ® -127,35 -0,84% 14.998,73
- MDAX ® -206,72 -0,71% 28.869,14
- TecDAX ® -16,36 -0,51% 3.187,09
- E-STOXX 50 ® -19,38 -0,46% 4.158,63
- NASDAQ 100 -254,21 -2,09% 11.912,39
- NIKKEI -205,35 -0,75% 27.239,13
- HANG SENG -230,09 -1,04% 21.842,33
Tops & Flops SWX SP HLTHCARE2 TR
| Tops | Kurs | % |
|---|---|---|
| IVF HARTMANN H. NA SF1,75 | 122,74 | +4,09% |
| SHL TELEMEDICINE N | 13,70 | +1,48% |
| XLIFE SCIENCES N | 34,50 | +1,47% |
| ADDEX THERAP. SF 0,01 | 0,000 | ±0,00% |
| Flops | Kurs | % |
| POLYPEPTIDE GROUP SF -,01 | 26,56 | -6,81% |
| NEWRON PHARMACEUT. EO-,20 | 3,07 | -1,92% |
| COSMO PHARMACEUT. EO-,26 | 65,50 | -0,76% |
| ADDEX THERAP. SF 0,01 | 0,000 | ±0,00% |
Kursperformance
| Zeitraum | Kurs | % |
|---|---|---|
| 1 Tag | -- | -- |
| 1 Woche | 3.348,46 | -0,58% |
| 1 Monat | 3.304,45 | +0,74% |
| 6 Monate | 3.538,19 | -5,91% |
| Lfd. Jahr (YTD) | 3.272,04 | +1,74% |
| 1 Jahr | 3.600,22 | -7,54% |
| 3 Jahre | 3.216,21 | +3,51% |
| 5 Jahre | 2.388,44 | +39,38% |
Kursdaten
| Kurs | 3.328,94 |
| Schluss Vortag | 3.326,47 |
| Eröffnung | 3.322,66 |
| Tages-Hoch | 3.337,50 |
| Tages-Tief | 3.312,58 |
| 52 Wochen-Hoch | 4.078,51 |
| 52 Wochen-Tief | 3.126,92 |
| Allzeit-Hoch | 12.638,70 |
| Allzeit-Tief | 813,31 |
Wertpapiere im SWX SP HLTHCARE2 TR (31)
| Name | Kurs | % | Absolut |
|---|---|---|---|
| ADDEX THERAP. SF 0,01 | 0,000€ | ±0,00% | ±0,000 |
| AEVIS VICTORIA NA SF 1 | 0,000€ | ±0,00% | ±0,000 |
| ALCON AG NAM. SF -,04 | 0,000€ | ±0,00% | ±0,000 |
| BASILEA PHARM.NA SF 1 | 0,000€ | ±0,00% | ±0,000 |
| COLTENE HLDG AG NAM.SF0,1 | 0,000€ | ±0,00% | ±0,000 |
| COSMO PHARMACEUT. EO-,26 | 65,50€ | -0,76% | -0,50 |
| EVOLVA HOLDING AG SF-,05 | 0,000€ | ±0,00% | ±0,000 |
| IDORSIA AG SF-,05 | 0,000€ | ±0,00% | ±0,000 |
| IVF HARTMANN H. NA SF1,75 | 122,74€ | +4,09% | +4,82 |
| KINARUS THERAP.NA SF 0,01 | 0,000€ | ±0,00% | ±0,000 |
| KUROS BIOSCI.AG NAM.SF-,1 | 0,000€ | ±0,00% | ±0,000 |
| LONZA GROUP AG NA SF 1 | 0,000€ | ±0,00% | ±0,000 |
| MEDACTA GROUP S.A. SF-,10 | 0,000€ | ±0,00% | ±0,000 |
| MOLECULAR PARTNERS SF 1 | 0,000€ | ±0,00% | ±0,000 |
| NEWRON PHARMACEUT. EO-,20 | 3,07€ | -1,92% | -0,06 |
| NOVARTIS NAM. SF 0,50 | 0,000€ | ±0,00% | ±0,000 |
| OBSEVA SA SF-,076923 | 0,000€ | ±0,00% | ±0,000 |
| POLYPEPTIDE GROUP SF -,01 | 26,56 | -6,81% | -1,94 |
| ROCHE HLDG AG GEN. | 0,000€ | ±0,00% | ±0,000 |
| SANTHERA PHARM.HD.SF 0,01 | 0,000€ | ±0,00% | ±0,000 |
| SHL TELEMEDICINE N | 13,70 | +1,48% | +0,20 |
| SIEGFRIED HL NA SF 18 | 0,000€ | ±0,00% | ±0,000 |
| SONOVA HLDG AG NA.SF 0,05 | 0,000€ | ±0,00% | ±0,000 |
| SPEXIS AG SF0,02 | 0,000€ | ±0,00% | ±0,000 |
| TECAN GRP AG NAM.SF 0,10 | 0,000€ | ±0,00% | ±0,000 |
| XLIFE SCIENCES N | 34,50 | +1,47% | +0,50 |
| YPSOMED HLDG SF 14,15 | 0,000€ | ±0,00% | ±0,000 |
